IONS in the 13F filings
Ionis Pharmaceuticals Inc · CUSIP 462222100
- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 18 Aug 2025
- latest of these filings; the earliest 30 Jul 2025
- Managers listing it
- 13
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 10 listed it in both
- Shares listed
- 53,730,757
- combined, among listed positions
- Reported value
- $2.1bn
- combined, at the quarter end
Among the 95 comparable managers: 8 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing IONS in Q2 2025
13 of 13 holders
Largest increases and reductions, by shares
Increases
- Woodline Partners LPnew position · 732,813 shares now+732,813
- Two Sigma Advisers LPexisting position · 2,667,611 shares now+575,600
- Capital World Investorsexisting position · 12,540,188 shares now+178,194
- Artisan Partners LPexisting position · 354,962 shares now+151,784
- Two Sigma Investments LPexisting position · 1,788,367 shares now+102,514
Reductions
- Wellington Management Group LLPexisting position · 6,345,776 shares now-2,070,645
- Hudson Bay Capital Management LPexisting position · 750,000 shares now-299,900
- Schonfeld Strategic Advisors LLCexisting position · 449,206 shares now-111,153
- ARK Investment Management LLCexisting position · 900,318 shares now-100,209
- PDT Partners LLCexisting position · 54,365 shares now-41,691
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2015 | 14 | $1.8bn | n.a. | n.a. |
| Q1 2016 | 7 | $1.1bn | n.a. | n.a. |
| Q2 2016 | 3 | $667m | n.a. | n.a. |
| Q3 2016 | 4 | $1.1bn | n.a. | n.a. |
| Q4 2016 | 7 | $1.6bn | n.a. | n.a. |
| Q1 2017 | 5 | $1.4bn | n.a. | n.a. |
| Q2 2017 | 6 | $1.9bn | n.a. | n.a. |
| Q3 2017 | 6 | $1.9bn | n.a. | n.a. |
| Q4 2017 | 7 | $1.9bn | n.a. | n.a. |
| Q1 2018 | 7 | $1.6bn | n.a. | n.a. |
| Q2 2018 | 6 | $1.6bn | n.a. | n.a. |
| Q3 2018 | 8 | $2.1bn | n.a. | n.a. |
| Q4 2018 | 11 | $2.1bn | n.a. | n.a. |
| Q1 2019 | 14 | $3.5bn | n.a. | n.a. |
| Q2 2019 | 11 | $2.8bn | n.a. | n.a. |
| Q3 2019 | 10 | $2.6bn | n.a. | n.a. |
| Q4 2019 | 10 | $2.5bn | n.a. | n.a. |
| Q1 2020 | 14 | $2.1bn | n.a. | n.a. |
| Q2 2020 | 12 | $2.6bn | n.a. | n.a. |
| Q3 2020 | 15 | $2.1bn | n.a. | n.a. |
| Q4 2020 | 14 | $2.5bn | n.a. | n.a. |
| Q1 2021 | 9 | $1.9bn | n.a. | n.a. |
| Q2 2021 | 10 | $1.8bn | n.a. | n.a. |
| Q3 2021 | 8 | $1.4bn | n.a. | n.a. |
| Q4 2021 | 9 | $1.3bn | n.a. | n.a. |
| Q1 2022 | 9 | $1.6bn | n.a. | n.a. |
| Q2 2022 | 12 | $1.6bn | n.a. | n.a. |
| Q3 2022 | 11 | $1.5bn | n.a. | n.a. |
| Q4 2022 | 9 | $1.2bn | n.a. | n.a. |
| Q1 2023 | 7 | $1.0bn | n.a. | n.a. |
| Q2 2023 | 10 | $1.3bn | n.a. | n.a. |
| Q3 2023 | 12 | $1.4bn | n.a. | n.a. |
| Q4 2023 | 14 | $1.9bn | 10 | 4 |
| Q1 2024 | 15 | $1.7bn | 9 | 5 |
| Q2 2024 | 17 | $2.1bn | 12 | 5 |
| Q3 2024 | 16 | $2.1bn | 11 | 7 |
| Q4 2024 | 11 | $1.7bn | 7 | 5 |
| Q1 2025 | 10 | $1.5bn | 7 | 3 |
| Q2 2025 | 13 | $2.1bn | 8 | 5 |
| Q3 2025 | 18 | $3.6bn | 9 | 8 |
| Q4 2025 | 15 | $4.9bn | 15 | 20 |
| Q1 2026 | 16 | $5.0bn | 21 | 13 |
| Q2 2026 | 13 | $5.5bn | 13 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IONS and LLY →IONS and JNJ →IONS and VRTX →Choose a stock to compare with IONS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IONS, latest filings →Back to the 13F Explorer →